ID: ALA5183252

Max Phase: Preclinical

Molecular Formula: C135H199N37O42

Molecular Weight: 3012.29

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)[C@@H](C)O)[C@@H](C)O)C(C)C)C(N)=O

Standard InChI:  InChI=1S/C135H199N37O42/c1-65(2)50-88(110(141)191)158-123(204)94(56-75-59-148-80-27-17-16-26-78(75)80)163-118(199)86(41-45-102(140)183)157-131(212)107(67(5)6)171-126(207)92(52-71-22-12-10-13-23-71)162-124(205)95(57-105(187)188)164-117(198)85(40-44-101(139)182)151-111(192)68(7)150-114(195)82(29-20-48-146-134(142)143)153-115(196)83(30-21-49-147-135(144)145)155-129(210)98(63-175)168-125(206)96(58-106(189)190)165-120(201)89(51-66(3)4)159-121(202)90(54-73-31-35-76(179)36-32-73)160-116(197)81(28-18-19-47-136)154-128(209)97(62-174)167-122(203)91(55-74-33-37-77(180)38-34-74)161-119(200)87(42-46-104(185)186)156-130(211)99(64-176)169-133(214)109(70(9)178)172-127(208)93(53-72-24-14-11-15-25-72)166-132(213)108(69(8)177)170-103(184)60-149-113(194)84(39-43-100(138)181)152-112(193)79(137)61-173/h10-17,22-27,31-38,59,65-70,79,81-99,107-109,148,173-180H,18-21,28-30,39-58,60-64,136-137H2,1-9H3,(H2,138,181)(H2,139,182)(H2,140,183)(H2,141,191)(H,149,194)(H,150,195)(H,151,192)(H,152,193)(H,153,196)(H,154,209)(H,155,210)(H,156,211)(H,157,212)(H,158,204)(H,159,202)(H,160,197)(H,161,200)(H,162,205)(H,163,199)(H,164,198)(H,165,201)(H,166,213)(H,167,203)(H,168,206)(H,169,214)(H,170,184)(H,171,207)(H,172,208)(H,185,186)(H,187,188)(H,189,190)(H4,142,143,146)(H4,144,145,147)/t68-,69+,70+,79-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,107-,108-,109-/m0/s1

Standard InChI Key:  LCPUAJWQZPHSID-CMHKWSRRSA-N

Associated Targets(Human)

Glucagon receptor 2563 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 3012.29Molecular Weight (Monoisotopic): 3010.4573AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Li L, Dai S, Liu JY, Wu W, Zhao QX, Wang X, Wang N, Xu ZH..  (2022)  Antagonistic Effect and In Vitro Activity of Dauricine on Glucagon Receptor.,  85  (8.0): [PMID:35834753] [10.1021/acs.jnatprod.2c00446]

Source